Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin dose comparison in intracranial atherosclerotic stenosis
ChiCTR-OPC-16009540Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Oct 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rosuvastatin in Cerebral atherosclerotic stenosis (ICAD), ischemic stroke and transient ischaemic attack (TIA) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Blood lipid levels and Neurologic function score. Started Oct 2016; status: recruiting.
02
Drugs
rosuvastatin
03
Conditions
Cerebral atherosclerotic stenosis (ICAD)ischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on ChiCTR-OPC-16009540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16009540.